Nanopore-Mediated Assembly Enables Precise and Continuous Synthesis of mRNA-Encapsulated Lipid Nanoparticles for COVID-19 Vaccines
ACS Nano · 28.07.2026 · 20 (29) · 20513-20529
DOI: 10.1021/acsnano.6c00729 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 16.07.2026. Verfasst von Zhixiang Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Materials Engineering, New Jersey Institute of Technology, Newark, New Jersey07103, United States. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Nanoparticles, RNA, Messenger, Lipids. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gustavus and Louise Pfeiffer Research Foundation Award, National Science Foundation Industry/University Cooperative Research Center for Membrane Science, Engineering and Technology, Shanghai Jiao Tong University Award.
Abstract (Originalsprache)
RNA therapeutics are reshaping modern medicine, as exemplified by the rapid deployment of lipid nanoparticle (LNP)-based mRNA vaccines during the COVID-19 pandemic. However, the ability to reproducibly generate LNPs with precisely defined physicochemical properties at scale remains a critical challenge, particularly as the particle size and size distribution strongly influence biodistribution, cellular uptake, and therapeutic efficacy. Conventional mixing technologies ensure reproducibility but offer limited control over interfacial mixing and nanoparticle assembly, constraining both tunability and scalability. We present a hollow fiber membrane (HFM)-based platform that leverages dense arrays of nanoscale pores to mediate uniform, highly localized interfacial mixing, enabling controlled lipid self-assembly and RNA encapsulation. This nanopore-mediated architecture allows continuous, high-throughput synthesis of LNPs with tunable particle sizes, narrow size distributions, and high encapsulation efficiencies, with particle characteristics directly correlated to the membrane pore size. HFM-derived LNPs exhibit robust in vitro transfection and potent in vivo immune responses and are compatible with multiple lipid chemistries and nucleic acid payloads, including mRNA vaccine constructs. Together, this work establishes HFM-based nanopore assembly as a versatile and scalable approach for producing well-defined LNPs, with direct relevance to the current and future mRNA vaccine and therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Materials Engineering, New Jersey Institute of Technology, Newark, New Jersey07103, United States.
- Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, National Key Laboratory of Innovative Immunotherapy, Shanghai Jiao Tong University, Shanghai200240, P. R.…
- Department of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey07103, United States.
ORCID-Profile: Xue-Qing Zhang, Xiaoyang Xu
Förderung
- Gustavus and Louise Pfeiffer Research Foundation Award
- National Science Foundation Industry/University Cooperative Research Center for Membrane Science, Engineering and Technology
- Shanghai Jiao Tong University Award
- National Science Foundation (NSF)
- Natural Science Foundation of Shanghai
- National Centre of Technology Innovation for Biopharmaceuticals
- Pudong New Area Scientific and Technological Development Foundation
Zitieren
APA
Liu, Z., Stewart, W., Teng, Y., Song, Y., Tang, M., Guo, Y., Zhang, X. Q., Sirkar, K. K., & Xu, X. (2026). Nanopore-Mediated Assembly Enables Precise and Continuous Synthesis of mRNA-Encapsulated Lipid Nanoparticles for COVID-19 Vaccines. ACS Nano, 20(29), 20513-20529. https://doi.org/10.1021/acsnano.6c00729
Vancouver
Liu Z, Stewart W, Teng Y, Song Y, Tang M, Guo Y, et al. Nanopore-Mediated Assembly Enables Precise and Continuous Synthesis of mRNA-Encapsulated Lipid Nanoparticles for COVID-19 Vaccines. ACS Nano. 2026;20(29):20513-20529. doi:10.1021/acsnano.6c00729
BibTeX
@article{Liu2026,
author = {Liu, Zhixiang and Stewart, William and Teng, Yilong and Song, Yufeng and Tang, Maoping and Guo, Yuxuan and Zhang, Xue-Qing and Sirkar, Kamalesh K and Xu, Xiaoyang},
title = {Nanopore-Mediated Assembly Enables Precise and Continuous Synthesis of mRNA-Encapsulated Lipid Nanoparticles for COVID-19 Vaccines},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {29},
pages = {20513--20529},
doi = {10.1021/acsnano.6c00729}
}
EUVIMED